The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

Diabetes Care

Volumn 34, Issue 2, 2011, Pages 464-467

  Singh, Premranjan P ^a   Abbott, J Dawn ^b   Lombardero, Manuel S ^c   Sutton Tyrrell, Kim ^c   Woodhead, Gail ^d   Venkitachalam, Lakshmi ^c   Tsapatsaris, Nicholas P ^d   Piemonte, Thomas C ^d   Lago, Rodrigo M ^d   Rutter, Martin K ^e,f   Nesto, Richard W ^d  

^a Munroe Regional Med Center   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTOR VARIABLE; PREVALENCE; REVASCULARIZATION; SEX DIFFERENCE; SMOKING;

AGED; ANKLE BRACHIAL INDEX; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL REVASCULARIZATION; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS;

EID: 79951705212     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1734     Document Type: Article

References (14)

1. Brooks MM, Frye RL, Genuth S, et al; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol 2006;97(12A): 9G-19G
2. Angioplasty Revascularization Investigation B; Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Am Heart J 2008;156:528-536
3. Kullo IJ, Bailey KR, Kardia SLR, Mosley TH Jr, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med 2003;8:237-242 (Pubitemid 38585137)
4. Zheng Z-J, Rosamond WD, Chambless LE, et al; ARIC Investigators. Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Prev Med 2005;29(Suppl. 1): 42-49 (Pubitemid 43021816)
5. Aboyans V, Criqui MH, McClelland RL, et al. Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg 2007;45: 319-327 (Pubitemid 46149994)
6. Palumbo PJ, O'Fallon WM, Osmundson PJ, Zimmerman BR, Langworthy AL, Kazmier FJ. Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive? Arch Intern Med 1991;151:717-721
7. Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2006;29:877-882 (Pubitemid 44115310)
8. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 2006; 113:388-393 (Pubitemid 43803200)
9. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004;109:733-739 (Pubitemid 38222892)
10. Sutton-Tyrrell K, Venkitachalam L, Kanaya AM, et al. Relationship of ankle blood pressures to cardiovascular events in older adults. Stroke 2008;39:863-869 (Pubitemid 351619539)
11. Chen Y, Huang Y, Li X, et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine 2009;36:262-267
12. Kallio M, Forsblom C, Groop P-H, Groop L, Lepäntalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care 2003;26:1241-1245 (Pubitemid 36929279)
13. Carter RE, Lackland DT, Cleary PA, et al; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial. Diabetes Care 2007;30:2646-2648
14. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-1324 (Pubitemid 33015522)